Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,054 | -14,163 | -10,571 | -6,230 | -36,065 |
| Depreciation Amortization | 1,068 | 776 | 538 | 306 | 1,236 |
| Accounts payable and accrued liabilities | 2,679 | 133 | 101 | -586 | 1,641 |
| Other Working Capital | 844 | -727 | -477 | -1,906 | -118 |
| Other Operating Activity | -1,878 | 1,651 | 1,529 | 1,602 | 1,461 |
| Operating Cash Flow | $-14,341 | $-12,330 | $-8,880 | $-6,814 | $-31,845 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 309 | 258 | 25 | 11 | -66 |
| Investing Cash Flow | $309 | $258 | $25 | $11 | $-66 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 8,812 |
| Debt Repayment | -9,401 | -7,720 | -7,500 | -7,500 | N/A |
| Common Stock Issued | 4,888 | 4,887 | 1,428 | N/A | N/A |
| Other Financing Activity | 431 | 431 | 0 | 0 | 0 |
| Financing Cash Flow | $-4,082 | $-2,402 | $-6,072 | $-7,500 | $8,812 |
| Beginning Cash Position | 19,468 | 19,468 | 19,468 | 19,468 | 42,567 |
| End Cash Position | 1,354 | 4,994 | 4,541 | 5,165 | 19,468 |
| Net Cash Flow | $-18,114 | $-14,474 | $-14,927 | $-14,303 | $-23,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,341 | -12,330 | -8,880 | -6,814 | -31,845 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -66 |
| Free Cash Flow | -14,341 | -12,330 | -8,880 | -6,814 | -31,911 |